| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $33.7M | +41.1% |
| SG&A Expense | $11.3M | -4.8% |
| Operating Income | -$45.0M | -25.9% |
| Income Tax | $0 | — |
| Net Income | -$51.9M | -47.5% |
| EPS (Basic) | -$4.25 | +38.9% |
| EPS (Diluted) | -$4.25 | +38.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.6M | +36.6% |
| Current Assets | $20.7M | +26.6% |
| Total Assets | $28.2M | +3.8% |
| Current Liabilities | $11.5M | +18.0% |
| Total Liabilities | $39.5M | +150.4% |
| Stockholders' Equity | -$11.3M | -199.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$37.1M | -13.4% |
| Capital Expenditures | $87K | +31.8% |
| Investing Cash Flow | -$84K | -162.5% |
| Financing Cash Flow | $42.3M | +9.6% |
| Free Cash Flow | -$37.2M | -13.4% |